| Old Articles: <Older 29791-29800 Newer> |
|---|
 |
The Motley Fool
April 22, 2008
Brian Lawler |
No Earnings Holes for Novartis The drugmaker holds its own in Q1; all three of its major divisions experienced sales growth, even in the face of some tough comparisons to last year.   |
The Motley Fool
April 22, 2008
Brian Orelli |
Amylin Treads Water One-drug wonders like Amylin Pharmaceuticals can't get away with stagnant growth. |
The Motley Fool
April 22, 2008
David Lee Smith |
Weatherford Weathers One-Time Distractions Take away the special items, and Weatherford International's quarterly results were solid. |
The Motley Fool
April 22, 2008
Toby Shute |
More Rig Wrangling With offshore dayrates booming, everyone wants a piece of today's existing rig fleet. Take a look at two current deals. |
The Motley Fool
April 22, 2008
Rich Duprey |
Foolish Forecast: No Sizzle at Candela In advance of earnings, analysts expect sales from aesthetic laser maker Candela to be essentially flat. |
The Motley Fool
April 22, 2008
Christopher Barker |
News Trumps Earnings for Teck Miner Teck Cominco stands strong despite an earnings lapse. |
The Motley Fool
April 22, 2008
Morgan Housel |
All Smiles at Western Union The debt markets are rattled, the mortgage industry has run out of steam, and banking giants are flirting with disaster, but money-transfer powerhouse Western Union will hear nothing of it. |
The Motley Fool
April 22, 2008
Rich Smith |
TI Stubbornly Remains a Buy Look past the near-term challenging business environment, and focus instead on TI's valuation. |
The Motley Fool
April 22, 2008
Brian Lawler |
Lilly in Full Financial Bloom Pharmaceutical Eli Lilly boosts revenue in the first quarter, but its drug-pipeline progress falls short of spectacular. |
The Motley Fool
April 22, 2008
Dave Mock |
Foolish Forecast: Qualcomm Holds Its Ground In advance of its quarterly earnings, analysts expect Qualcomm to continue to show their resilience in a tough market. |
| <Older 29791-29800 Newer> Return to current articles. |
